Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $2.26 Million - $2.75 Million
10,000 New
10,000 $2.42 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $23.8 Million - $28.3 Million
-110,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $7.04 Million - $7.83 Million
30,000 Added 37.5%
110,000 $28 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $15.8 Million - $19.4 Million
80,000 New
80,000 $18.9 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $18.5 Million - $20.9 Million
-100,000 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $16.6 Million - $18.7 Million
100,000 New
100,000 $18.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.